4.7 Article

MICAL2PV suppresses the formation of tunneling nanotubes and modulates mitochondrial trafficking

Journal

EMBO REPORTS
Volume 22, Issue 7, Pages -

Publisher

WILEY
DOI: 10.15252/embr.202052006

Keywords

F-actin; lung cancer; Miro2; mitochondria; tunneling nanotubes

Funding

  1. National Key R&D Development Program of China [2019YFA0508603]
  2. National Natural Science Foundation of China [31971075, 31671174]
  3. National Institutes of Health [R01CA175360, R01GM123557, P30GM106397]

Ask authors/readers for more resources

MICAL2PV is a novel TNT regulator that suppresses formation and modulates mitochondrial distribution, with its MO domain playing a key role in activity. Down-regulation of MICAL2PV enhances cell survival to chemotherapeutic drugs.
Tunneling nanotubes (TNTs) are actin-rich structures that connect two or more cells and mediate cargo exchange between spatially separated cells. TNTs transport signaling molecules, vesicles, organelles, and even pathogens. However, the molecular mechanisms regulating TNT formation remain unclear and little is known about the endogenous mechanisms suppressing TNT formation in lung cancer cells. Here, we report that MICAL2PV, a splicing isoform of the neuronal guidance gene MICAL2, is a novel TNT regulator that suppresses TNT formation and modulates mitochondrial distribution. MICAL2PV interacts with mitochondrial Rho GTPase Miro2 and regulates subcellular mitochondrial trafficking. Moreover, down-regulation of MICAL2PV enhances survival of cells treated with chemotherapeutical drugs. The monooxygenase (MO) domain of MICAL2PV is required for its activity to inhibit TNT formation by depolymerizing F-actin. Our data demonstrate a previously unrecognized function of MICAL2 in TNT formation and mitochondrial trafficking. Furthermore, our study uncovers a role of the MICAL2PV-Miro2 axis in mitochondrial trafficking, providing a mechanistic explanation for MICAL2PV activity in suppressing TNT formation and in modulating mitochondrial subcellular distribution.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available